Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Clevidipine (Cleviprex): The ICU Nurse's Guide

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

Clevidipine is the vasodilator you reach for when you want blood-pressure control that turns on a dime. It is an ultra-short-acting calcium-channel blocker delivered in a milky lipid emulsion, which makes it beautifully titratable and introduces a few cautions the other antihypertensive drips don't have. Here is what to know.

The short version: Clevidipine is a dihydropyridine calcium-channel blocker that dilates arterioles to lower blood pressure. Its half-life is roughly one minute, so it titrates almost like nitroprusside without the cyanide risk. It is formulated in a 20% lipid emulsion (like propofol), so it is contraindicated in egg/soy allergy and severe lipid disorders, and the lipid load counts toward caloric intake. Start ~1–2 mg/hr and double roughly every 90 seconds to effect.

How clevidipine works

As a dihydropyridine, clevidipine blocks L-type calcium channels in arteriolar smooth muscle, producing selective arterial vasodilation and afterload reduction with little effect on veins or on cardiac contractility. What sets it apart is its metabolism: it is broken down by blood and tissue esterases, independent of liver or kidney function, giving it an extraordinarily short half-life. That is why its onset and offset are measured in minutes — you change the rate and see the pressure move almost immediately, then it clears just as fast when you stop.

Dosing and titration

ParameterTypical value
Starting dose1–2 mg/hr
TitrationDouble the dose roughly every 90 seconds initially, then slow as target nears
Usual range~4–21 mg/hr
Half-life~1 minute

Because clevidipine clears so quickly, a doubling strategy is standard: you increase aggressively at first to reach the target, then take smaller steps as you close in. The lipid vehicle limits how long a single vial and line can hang (strict aseptic handling and a time limit apply, since the emulsion supports microbial growth), so nurses follow the tubing-change and hang-time rules closely.

Bedside rule of thumb: Clevidipine's one-minute half-life is its superpower — if the pressure overshoots, turning the pump down fixes it within a couple of minutes, no antidote needed. That forgiveness is why it is popular for neuro and cardiac cases where tight targets matter.

The lipid-emulsion cautions

Allergy. The emulsion contains egg lecithin and soybean oil, so clevidipine is contraindicated in patients with allergies to eggs, egg products, soy, or soy products — the same warning you know from propofol.
Lipid metabolism. It is contraindicated in defective lipid metabolism (e.g., pathologic hyperlipidemia, lipoid nephrosis, acute pancreatitis with hyperlipidemia). The lipid load also contributes calories, so it factors into nutrition accounting on long infusions.

Beyond the vehicle, the drug's own effects to watch are reflex tachycardia, headache, and — as with any potent vasodilator — the potential to overshoot into hypotension, though the rapid offset makes that easy to correct.

Clevidipine vs nicardipine

Both are dihydropyridine drips for acute hypertension. Nicardipine has a longer duration, so it is smoother but slower to adjust and slower to wear off. Clevidipine's ultra-short half-life makes it the choice when you need rapid, precise, moment-to-moment control — but at higher drug cost and with the lipid cautions. Many units keep both, choosing based on how tightly and how quickly the pressure must be steered.

Why CRNA students should know it

On the CRNA path, clevidipine is a favorite for intraoperative blood-pressure control precisely because of its titratability — the ability to blunt a hypertensive surge and then let it clear in minutes is exactly what anesthesia demands. Knowing the calcium-channel mechanism, the esterase metabolism that bypasses organ function, and the propofol-style lipid allergy carries directly into the OR.

Bottom line

Clevidipine is the ultra-titratable arterial vasodilator: one-minute half-life, organ-independent clearance, and the forgiveness that comes with rapid offset. Respect the egg/soy allergy, the lipid-metabolism contraindications, and the caloric load, follow the hang-time rules, and it gives you blood-pressure control few other drips can match. Learn it now for the ICU and the OR both.

Related pharmacology: compare with nicardipine and labetalol, nitroprusside, and hydralazine for the full acute-hypertension toolkit.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.